Value of 18F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment
Crossref DOI link: https://doi.org/10.1007/s00259-015-3287-z
Published Online: 2016-01-11
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Palard-Novello, X.
Querellou, S.
Gouillou, M.
Saraux, A.
Marhadour, T.
Garrigues, F.
Abgral, R.
Salaün, P. Y.
Devauchelle-Pensec, V.
Funding for this research was provided by:
Roche-Chugai
Text and Data Mining valid from 2016-01-11